Prapela Receives FDA’s Breakthrough Device Designation to Investigate the Use of Stimulation to Treat Apnea of Prematurity
/
DateJan 05 2023
FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threatening or debilitating conditions.... Read More →

















